← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 1, 2012Last known activity
Oct 31, 2018
Acquired by NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks on Oct 19, 2015
Timeline
Drugs by trial phase (4 distinct, 3 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT03476681Lead sponsorPhase 1Oct 31, 2018
- NCT01834235Study directorPhase 1/Phase 2Apr 1, 2013
- NCT01834235Lead sponsorPhase 1/Phase 2Apr 1, 2013
- NCT01040000Study directorPhase 1/Phase 2Jan 1, 2012
- NCT01040000Lead sponsorPhase 1/Phase 2Jan 1, 2012
Details
- Founded
- Dallas, TX, US Feb 1, 2012
- Last known activity
- Oct 31, 2018